Brief: Humanigen Inc Says Lenzilumab Treatment May Provide Enhanced Likelihood Of Survival Without Ventilation In Hospitalized Black And African-American Covid-19 Patients
Aug 4 (Reuters) - Humanigen Inc HGEN.O :
* LENZILUMAB TREATMENT MAY PROVIDE ENHANCED LIKELIHOOD OF
SURVIVAL
WITHOUT VENTILATION IN HOSPITALIZED BLACK AND AFRICAN-AMERICAN
COVID-19 PATIENTS
* HUMANIGEN INC - LIVE-AIR PHASE 3 STUDY MET ITS PRIMARY
ENDPOINT
OF SURVIVAL WITHOUT VENTILATION
Source text for Eikon: ID:nBw3sMS3da
Further company coverage: HGEN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Humanigen
See all newsPress Digest: Wall Street Journal - Jan 5
Covid: 19 treatment developer Humanigen files for Chapter 11 bankruptcy
Brief: Humanigen Files For Voluntary Chapter 11 Bankruptcy - Court Filing
Brief: Covid-19 Treatment Developer Humanigen Files For Bankruptcy - WSJ
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners